Erythrocytosis familial, 1
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
29
|
14
|
0.800 |
strong |
0.867 |
15 |
7
|
1993 |
2018 |
Polycythemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
82
|
22
|
0.500 |
None |
1.000 |
15 |
2
|
1993 |
2018 |
Erythrocytosis
|
phenotype |
Hemic and Lymphatic Diseases
|
Finding
|
9
|
1
|
0.500 |
strong |
1.000 |
2 |
|
2002 |
2006 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.390 |
None |
0.900 |
10 |
|
2002 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.380 |
None |
0.889 |
9 |
|
2002 |
2019 |
Familial erythrocytosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
17
|
2
|
0.380 |
None |
0.875 |
8 |
|
1994 |
2007 |
Acute Erythroblastic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
302
|
5
|
0.370 |
None |
1.000 |
7 |
1
|
1992 |
2009 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.330 |
None |
1.000 |
4 |
|
2002 |
2011 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.330 |
None |
1.000 |
3 |
|
2010 |
2014 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.320 |
None |
1.000 |
3 |
|
2004 |
2017 |
Thyroid Neoplasm
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1164
|
135
|
0.310 |
None |
1.000 |
1 |
|
2006 |
2006 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Nerve Degeneration
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
165
|
17
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Thyroid Gland Follicular Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
202
|
14
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.230 |
None |
1.000 |
3 |
|
2011 |
2016 |
Kidney Failure, Chronic
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
827
|
425
|
0.220 |
None |
1.000 |
3 |
|
2003 |
2016 |
Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
877
|
43
|
0.210 |
None |
1.000 |
1 |
|
2013 |
2013 |
Brain Hypoxia
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
12
|
|
0.200 |
None |
1.000 |
2 |
|
2011 |
2013 |
Chronic kidney disease stage 5
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
666
|
194
|
0.200 |
None |
1.000 |
1 |
|
2016 |
2016 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Adult Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
13
|
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |